Notch inhibits osteoblast differentiation and causes osteopenia.

Notch inhibits osteoblast differentiation and causes osteopenia. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Notch inhibits osteoblast differentiation and causes osteopenia. Abstract Text:

Notch receptors are determinants of cell fate decisions. To define the role of Notch in the adult skeleton, we created transgenic mice overexpressing the Notch intracellular domain (NICD) under the control of the type I collagen promoter. First-generation transgenics were small and osteopenic. Bone histomorphometry revealed that NICD caused a decrease in bone volume, secondary to a reduction in trabecular number; osteoblast and osteoclast number were decreased. Low fertility of founder mice and lethality of young pups did not allow the complete establishment of transgenic lines. To characterize the effect of Notch overexpression in vitro, NICD was induced in osteoblasts and stromal cells from Rosa(notch) mice, in which a STOP cassette flanked by lox(P) sites is upstream of NICD, by transduction with an adenoviral vector expressing Cre recombinase (Cre) under the control of the cytomegalovirus (CMV) promoter (Ad-CMV-Cre). NICD impaired osteoblastogenesis and inhibited Wnt/beta-catenin signaling. To determine the effects of notch1 deletion in vivo, mice in which notch1 was flanked by lox(P) sequences (notch1(loxP/loxP)) were mated with mice expressing Cre recombinase under the control of the osteocalcin promoter. Conditional null notch1 mice had no obvious skeletal phenotype, possibly because of rescue by notch2; however, 1-month-old females exhibited a modest increase in osteoclast surface and eroded surface. Osteoblasts from notch1(loxP/loxP) mice, transduced with Ad-CMV-Cre and transfected with Notch2 small interfering RNA, displayed increased alkaline phosphatase activity. In conclusion, Notch signaling in osteoblasts causes osteopenia and impairs osteo-blastogenesis by inhibiting the Wnt/beta-catenin pathway.

Notch inhibits osteoblast differentiation and causes osteopenia. Publishing Authors By Initials

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Notch inhibits osteoblast differentiation and causes osteopenia. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Endocrinology

VOLUME: 149

Page Numbers: 3890-9

Journal Abbreviation: Endocrinology

ISSN: 0013-7227

DAY: 17

MONTH: 04

YEAR: 2008

Notch inhibits osteoblast differentiation and causes osteopenia. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 375040

Notch inhibits osteoblast differentiation and causes osteopenia. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Notch inhibits osteoblast differentiation and causes osteopenia. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Notch inhibits osteoblast differentiation and causes osteopenia.

AFFILIATION: Department of Research, Saint Francis Hospital and Medical Center, 114 Woodland Street, Hartford, Connecticut 06105-1299. ecanalis@stfranciscare.org.

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Endocrinology

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Notch inhibits osteoblast differentiation and causes osteopenia Related Publications

• Activation of the ERK pathway in osteoblastic cells, role of gremlin and BMP-2.
• Bone morphogenetic protein-2 suppresses collagenase-3 promoter activity in osteoblasts through a runt domain factor 2 binding site.
• Bone morphogenetic proteins induce gremlin, a protein that limits their activity in osteoblasts.
• CCAAT/Enhancer-binding protein homologous protein (CHOP) decreases bone formation and causes osteopenia.
• CCAAT/enhancer binding protein homologous protein (DDIT3) induces osteoblastic cell differentiation.
• Conditional deletion of gremlin causes a transient increase in bone formation and bone mass.
• Connective tissue growth factor enhances osteoblastogenesis in vitro.
• Effect of growth factors on bone cell replication and differentiation.
• Effects of cortisol and bone morphogenetic protein-2 on stromal cell differentiation: correlation with CCAAT-enhancer binding protein expression.
• Expression and regulation of CCN genes in murine osteoblasts.
• Gene delivery by retroviruses.
• Growth hormone, insulin-like growth factors, and the skeleton.
• Local bone growth factors.
• Nephroblastoma overexpressed (Nov) inhibits osteoblastogenesis and causes osteopenia.
• Nephroblastoma overexpressed (nov) is a novel bone morphogenetic protein antagonist.
• Notch inhibits osteoblast differentiation and causes osteopenia.
• Notch signaling in osteoblasts.
• Regulation of collagenase-3 by bone morphogenetic protein-2 in bone cell cultures.
• Skeletal overexpression of connective tissue growth factor impairs bone formation and causes osteopenia.
• Transcriptional regulation of connective tissue growth factor by cortisol in osteoblasts.
• Transient focal lesion in the splenium of the corpus callosum: MR imaging with an attempt to clinical-physiopathological explanation and review of the literature.
• Twisted gastrulation, a bone morphogenetic protein agonist/antagonist, is not required for post-natal skeletal function.